Gisadenafil besylate

Overview

Gisadenafil besylate (UK 369003-26) is a specific, orally active phosphodiesterase 5 ( PDE5 ) inhibitor with an IC 50 of 3.6 nM and prevents degradation of cyclic guanosine monophosphate (cGMP).

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-108619
• CAS No.: 334827-98-4
• Molecular Formula: C29H39N7O8S2
• Molecular Weight: 677.79
• Purity: 99.74%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source